Linking HIV-infected persons of color and injection drug users to HIV medical and other services: The California Bridge Project

被引:35
|
作者
Molitor, F
Kuenneth, C
Waltermeyer, J
Mendoza, M
Aguirre, A
Brockmann, K
Crump, C
机构
[1] ETR Associates, Sacramento, CA 95818 USA
[2] Univ Calif Davis, Ctr Hlth Serv Res Primary Care, Davis, CA 95616 USA
[3] Calif Dept Hlth Serv, Off AIDS, Sacramento, CA USA
关键词
D O I
10.1089/apc.2005.19.406
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Our objectives were to describe the strategies and successes in linking out-of-treatment HIV-infected persons of color and injection drug users (IDUs) to a comprehensive HIV care, treatment, and prevention program and other community services. Peer-based outreach staff at 21 sites throughout California provided assessments and referrals to 1453 persons living with HIV but without routine care. A linkage was defined as the receipt of a referred service. Half (49.7%) of persons of color and 41.6% of IDUs received services at a California Early Intervention Program (EIP) site after the date of first contact with peer staff; 58.1% of clients referred to EIP were linked to the program. IDUs were less likely to link to EIP. However, IDU clients were less likely to be referred to EIP, and more likely to be referred and linked to other community programs. Interventions such as the California Bridge Project can effectively link HIV-infected persons from marginalized populations to care, treatment, and prevention services. Programs that address immediate needs such as housing are more appealing to IDUs than programs offering HIV medical care.
引用
收藏
页码:406 / 412
页数:7
相关论文
共 50 条
  • [31] Homelessness and Adherence to Antiretroviral Therapy among a Cohort of HIV-Infected Injection Drug Users
    Anita Palepu
    M-J Milloy
    Thomas Kerr
    Ruth Zhang
    Evan Wood
    Journal of Urban Health, 2011, 88 : 545 - 555
  • [32] SERUM-ALBUMIN AND OTHER PARAMETERS IN HIV-INFECTED INTRAVENOUS-DRUG-USERS
    CIRASINO, L
    LANDONIO, G
    IMBRIANI, M
    RAGAINI, S
    JOURNAL OF INFECTION, 1993, 26 (02) : 229 - 232
  • [33] Staging for antiretroviral therapy among HIV-infected drug users
    Wood, E
    Hogg, RS
    Bonner, S
    Kerr, T
    Li, K
    Palepu, A
    Guillemi, S
    Schechter, MT
    Montaner, JSG
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (10): : 1175 - 1177
  • [34] Oral lesions as markers of severe immunosuppression in HIV-infected homosexual men and injection drug users
    Begg, MD
    Panageas, KS
    MitchellLewis, D
    Bucklan, RS
    Phelan, JA
    Lamster, IB
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 1996, 82 (03): : 276 - 283
  • [35] The prevention and care of HIV-infected drug users in contemporary Brazil
    Bastos, Francisco I.
    SUBSTANCE USE & MISUSE, 2006, 41 (6-7) : 833 - 834
  • [36] Serial position effects in HIV-infected injecting drug users
    Waldrop, D
    Ownby, RL
    Kumar, M
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2004, 114 (04) : 493 - 516
  • [37] Longitudinal neuropsychological evaluation of HIV-infected intravenous drug users
    Bono, G
    Mauri, M
    Sinforiani, E
    Barbarini, G
    Minoli, L
    Fea, M
    ADDICTION, 1996, 91 (02) : 263 - 268
  • [38] CARING FOR HIV-INFECTED DRUG-USERS - A PROVIDERS PERSPECTIVE
    SELWYN, PA
    CUTIS, 1995, 56 (05): : 250 - 252
  • [39] Caring for HIV-infected drug users: A provider's perspective
    Selwyn, PA
    BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE, 1995, 72 (01) : 211 - 216
  • [40] Vitamin D deficiency and persistent proteinuria among HIV-infected and uninfected injection drug users
    Estrella, Michelle M.
    Kirk, Gregory D.
    Mehta, Shruti H.
    Brown, Todd T.
    Fine, Derek M.
    Atta, Mohamed G.
    Lucas, Gregory M.
    AIDS, 2012, 26 (03) : 295 - 302